Principal Financial Group’s iTeos Therapeutics ITOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,430
| Closed | -$180K | – | 2462 |
|
|
2023
Q4 | $180K | Sell |
16,430
-135,912
| -89% | -$1.49M | ﹤0.01% | 2186 |
|
|
2023
Q3 | $1.67M | Buy |
152,342
+5,555
| +4% | +$60.8K | ﹤0.01% | 1789 |
|
|
2023
Q2 | $1.94M | Sell |
146,787
-8,370
| -5% | -$111K | ﹤0.01% | 1770 |
|
|
2023
Q1 | $2.11M | Sell |
155,157
-3,331
| -2% | -$45.3K | ﹤0.01% | 1752 |
|
|
2022
Q4 | $3.1M | Sell |
158,488
-10,661
| -6% | -$208K | ﹤0.01% | 1681 |
|
|
2022
Q3 | $3.22M | Buy |
169,149
+1,399
| +0.8% | +$26.6K | ﹤0.01% | 1628 |
|
|
2022
Q2 | $3.46M | Buy |
167,750
+31,004
| +23% | +$639K | ﹤0.01% | 1673 |
|
|
2022
Q1 | $4.4M | Buy |
+136,746
| New | +$4.4M | ﹤0.01% | 1702 |
|
|
2021
Q3 | – | Sell |
-8,090
| Closed | -$208K | – | 2599 |
|
|
2021
Q2 | $208K | Buy |
+8,090
| New | +$208K | ﹤0.01% | 2467 |
|